Skip to main content

Table 4 Number and percentage of CIN2+ cases based on the biopsies according to cytology result and previous radiotherapy status read under FPGS orientation

From: Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study

Cytology result

No previous radiotherapy

Previous radiotherapy

PR

95% CI (PR)

N (%)

N (%)

ASCUS + ASCH + AGC

41 (32.5)

10 (50.0)

1.54

0.93 – 2.55

LSIL

20 (15.9)

2 (10.0)

0.63

0.16 – 2.49

HSIL or worse

65 (51.6)

8 (40.0)

0.78

0.44 – 1.36